PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Feb 2003 (Vol: 2003, Issue: 33)

Next Issue >>

Section: Company Profile
SkyePharma plc Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Schering AG to Market Campath® in South East Asia Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
SkyePharma Licenses Further Solaraze Rights to Shire; Makes Investment in Micap Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
Section: General
SkyePharma’s Deal Strategy Published: 3 Feb-2003
By: Business Review Editor
Abstract
Drug Delivery Alliance Development Process Published: 3 Feb-2003
By: Business Review Editor
Abstract
Therapy Focus: Age-related Macular Degeneration Published: 3 Feb-2003
By: Business Review Editor
Abstract
Section: Licensing
King Acquires Elan’s US Primary Care Business Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
GSK Licenses Rights to Preclinical HIV Compound Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
Watson Pharmaceuticals Enters Agreement for Novartis’ Headache Treatments Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Roche to Bid US$1.2 B for Diabetes Firm, Disetronic Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
CAT and OGS in US$176 M Merger Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
J&J to Acquire Scios Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Pharmacopeia Signs Two Collaborative R&D Deals Published: 3 Feb-2003
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in

Bookmarks

Bookmark PharmaDeals through one of these social networks.